Hefei Kosheng Jingpeptide Biotechnology Co., Ltd.

Founded in January 2018, Hefei Shengjing Peptide Biotechnology Co., Ltd. is a high-tech enterprise with peptide as its core. The founding team came from Tsinghua University and China University of Science and Technology. The company has created KPDS (KS-V Peptide Discovery Services Platform), a leading international peptide drug discovery platform, which provides pharmaceutical companies, biotechnology companies and scientific research units with one-stop, customized and strategic peptide discovery services. Business focuses on polypeptide drugs, nuclide conjugate drugs (RDCs), polypeptide drug conjugates (PDCs), multifunctional peptide conjugates, and disease diagnosis and health care functional products; specializes in the custom synthesis of difficult polypeptides (toxin peptides, ubiquitin and ubiquitin probes, modified histones and nucleosome assemblies), drug peptide transformation and optimization, polypeptide process development, and polypeptide library construction. The registered capital is about 41.5 million yuan, and the team size is about 50–99 people.

Hefei Kosheng Jingpeptide Biotechnology Co., Ltd. is located at Hefei, Anhui Province, China.